Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Brain : a journal of neurology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1093/brain/awr277PMID 22108576PMCID PMC3316476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Frequency of Dementia in Parkinson’s Disease

  2013cited by this paper
• Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

  2011cited by this paper
• The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status

  2011cited by this paper
• Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study)

  2011cited by this paper
• Patterns of cortical thickness and surface area in early Parkinson's disease

  2011cited by this paper
• Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia

  2010cited by this paper
• CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease

  2010cited by this paper
• Mild cognitive impairment in Parkinson disease

  2010cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010cited by this paper
• Synergistic Interactions between Aβ, Tau, and α-Synuclein: Acceleration of Neuropathology and Cognitive Decline

  2010cited by this paper
• Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia

  2010cited by this paper
• Unified Parkinson's disease rating scale と三次元動作解析を用いたパーキンソン病患者のリハビリテーションの有効性の検討

  2010cited by this paper
• A 12-year population-based study of psychosis in Parkinson disease.

  2010cited by this paper
• Robust and expanded norms for the Dementia Rating Scale.

  2010cited by this paper
• CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study

  2010cited by this paper
• Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease.

  2010cited by this paper
• Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index.

  2009cited by this paper
• Cerebrospinal tau, phospho‐tau, and beta‐amyloid and neuropsychological functions in Parkinson's disease

  2009cited by this paper
• Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia

  2009cited by this paper
• Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction

  2009cited by this paper
• Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.

  2009cited by this paper
• Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer Pathology

  2009cited by this paper
• P3‐080: Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short‐term conversion to AD: Results from ADNI

  2009cited by this paper
• Temporal lobe changes in early, untreated Parkinson's disease

  2009cited by this paper
• Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease.

  2009cited by this paper
• The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort.

  2009cited by this paper
• Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics.

  2009cited by this paper
• Medical decision‐making capacity in cognitively impaired Parkinson's disease patients without dementia

  2008cited by this paper
• Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline

  2008cited by this paper
• The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years

  2008cited by this paper
• Cut‐off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease

  2008cited by this paper
• Structural and functional biomarkers of prodromal Alzheimer's disease: A high-dimensional pattern classification study

  2008cited by this paper
• Imaging amyloid deposition in Lewy body diseases

  2008cited by this paper
• Detection of prodromal Alzheimer's disease via pattern classification of magnetic resonance imaging.

  2008cited by this paper
• A Volumetric Magnetic Resonance Imaging Study of Entorhinal Cortex Volume in Dementia with Lewy Bodies

  2008cited by this paper
• A Modern Hypothesis: The Distinct Pathologies of Dementia Associated with Parkinson’s Disease versus Alzheimer’s Disease

  2008cited by this paper
• Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia

  2008cited by this paper
• Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease

  2008cited by this paper
• The Unified Parkinson's Disease Rating Scale: Validation study of the mentation, behavior, and mood section

  2007cited by this paper
• Cognitive Changes in Parkinson’s Disease Patients with Visual Hallucinations

  2007cited by this paper
• Assessing cognitive change in Parkinson's disease: development of practice effect-corrected reliable change indices.

  2007cited by this paper
• Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

  2007cited by this paper
• A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations

  2007cited by this paper
• COMPARE: Classification of Morphological Patterns Using Adaptive Regional Elements

  2007cited by this paper
• Subtypes of mild cognitive impairment in parkinson's disease: Progression to dementia

  2006cited by this paper
• A magnetic resonance imaging study of patients with Parkinson’s disease with mild cognitive impairment and dementia using voxel-based morphometry

  2006cited by this paper
• The Alzheimer's disease neuroimaging initiative.

  2005cited by this paper
• Neuropathology of dementia in Parkinson's disease: A prospective, community‐based study

  2005cited by this paper
• Temporal lobe atrophy on MRI in Parkinson disease with dementia

  2005cited by this paper
• Hallucinations and sleep disorders in PD

  2005cited by this paper
• Cognitive Predictors of Dementia in Parkinson’s Disease: A Community-Based, 4-Year Longitudinal Study

  2005cited by this paper
• Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia

  2005cited by this paper
• Cognitive status correlates with neuropathologic stage in Parkinson disease

  2005cited by this paper
• Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

  2004cited by this paper
• Dementia Rating Scale-2 (DRS-2)

  2004cited by this paper
• Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson’s disease is related to cognitive impairment

  2004cited by this paper
• Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism

  2004cited by this paper
• Very High-Resolution Morphometry Using Mass-Preserving Deformations and HAMMER Elastic Registration

  2003cited by this paper
• Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

  2003cited by this paper
• Parkinson's disease is associated with hippocampal atrophy

  2003cited by this paper
• Use of functional imaging in parkinsonism and dementia

  2003cited by this paper
• Cognitive impairments in advanced PD without dementia

  2002cited by this paper
• Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response.

  2002cited by this paper
• Memory and executive function impairment predict dementia in Parkinson's disease

  2002cited by this paper
• Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group.

  2002cited by this paper
• Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease

  2002cited by this paper
• HAMMER: hierarchical attribute matching mechanism for elastic registration

  2002cited by this paper
• β-Amyloid peptides enhance α-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

  2001cited by this paper
• Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.

  2001cited by this paper
• Risk of dementia in Parkinson’s disease

  2001cited by this paper
• beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.

  2001cited by this paper
• Hallucinations, REM sleep, and Parkinson’s disease

  2000cited by this paper
• Neuroimmunoregulation of Androgens in the Adrenal Gland and the Skin

  2000cited by this paper
• Axon pathology in Parkinson ’ s disease and Lewy body dementia hippocampus contains a-, b-, and g-synuclein

  1999cited by this paper
• Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.

  1999cited by this paper
• Neuropsychological prediction of dementia in Parkinson’s disease

  1998cited by this paper
• An image-processing system for qualitative and quantitative volumetric analysis of brain images.

  1998cited by this paper
• Palliative therapy in the terminal stage of neurological disease

  1997cited by this paper
• Point of view: Dementia in Parkinson's disease.

  1997cited by this paper
• Cognitive deficits in Parkinson’s disease

  1996cited by this paper
• Frequency of dementia in Parkinson disease.

  1996cited by this paper
• Cerebral glucose metabolism in Parkinson's disease with and without dementia.

  1992cited by this paper
• Variable expression of Parkinson's disease

  1990cited by this paper
• Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version.

  1986cited by this paper
• Clinical Gerontology: A Guide to Assessment and Intervention

  1986cited by this paper
• Recent Developments in Parkinson's Disease

  1986cited by this paper
• Random-effects models for longitudinal data.

  1982cited by this paper

• Potential Effects of Music on Non-Motor Symptoms in Parkinson’s Disease: Translating Mechanisms to Therapy

  2026cites this paper
• Cortical volumetry and longitudinal cognitive changes in Parkinson’s disease: insights from the COPPADIS cohort

  2025cites this paper
• Cognition-Enhancing Effects of Caterpillar Medicinal Mushroom Cordyceps militaris (Ascomycota) and Cordycepin in a Scopolamine-Induced Mouse Model.

  2025cites this paper
• Dancing through time: Cognitive changes over six years of community dance in Parkinson's disease

  2025cites this paper
• Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson’s disease

  2025cites this paper
• Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson’s disease

  2025cites this paper
• Biomechanical perspectives on traumatic brain injury in the elderly: a comprehensive review

  2025cites this paper
• Neuroanatomical Correlate of Memory Impairment in Parkinson's Disease Assessed by Composite Recall and Recognition Test with MMSE.

  2025cites this paper
• The ameliorative effect of sodium butyrate alone or combined with vitamin E on oxidative stress and neurodegeneration in an experimental model of Alzheimer’s disease

  2025cites this paper
• Hypoperfusion in Alzheimer’s Disease–Prone Regions and Dementia Conversion in Parkinson’s Disease

  2024cites this paper
• Mild cognitive impairment in Parkinson's disease: current view

  2024cites this paper
• Advanced brain aging in Parkinson’s disease with cognitive impairment

  2024cites this paper
• Revealing the heterogeneity of plasma protein and cognitive decline trajectory among Mild Cognitive Impairment patients by clustering of brain atrophy features

  2024cites this paper
• DRD3 Predicts Cognitive Impairment and Anxiety in Parkinson’s Disease: Susceptibility and Protective Effects

  2024cites this paper
• Brain age in genetic and idiopathic Parkinson's disease

  2024cites this paper
• Medial temporal atrophy predicts the limbic comorbidities in lewy body disease

  2024cites this paper
• GC/MS and LC‐ESI‐MS Analysis of Conocarpus erectus Leaves Extract via Regulating Amyloid‐β‐Peptide, Tau Protein, Neurotransmitters, Inflammation and Oxidative Stress against AlCl3‐Induced Alzheimer's Disease in Rats

  2024cites this paper
• Mild Behavioral Impairment in Parkinson’s Disease: An Updated Review on the Clinical, Genetic, Neuroanatomical, and Pathophysiological Aspects

  2024cites this paper
• Mapping brain morphology to cognitive deficits: a study on PD-CRS scores in Parkinson’s disease with mild cognitive impairment

  2024cites this paper
• Neuroanatomical Signature of the Transition from Normal Cognition to MCI in Parkinson's Disease

  2024cites this paper
• Neuroimaging and plasma evidence of early white matter loss in Parkinson’s disease with poor outcomes

  2024cites this paper
• Neuroimaging and plasma marker evidence for white matter macrostructure loss in Parkinson’s disease

  2023cites this paper
• Characterizing Alzheimer’s Disease Biomarker Cascade Through Non-linear Mixed Effect Models

  2023cites this paper
• Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks

  2023cites this paper
• Cognitive dysfunction in de novo Parkinson disease: Remitting vs. progressive cognitive impairment.

  2023cites this paper
• A neuroimaging measure to capture heterogeneous patterns of atrophy in Parkinson’s disease and dementia with Lewy bodies

  2023cites this paper
• Third ventricular width by transcranial sonography is associated with cognitive impairment in Parkinson's disease

  2023cites this paper
• Mild cognitive impairment in dementia with Lewy bodies: an update and outlook

  2023cites this paper
• Characterization of Brain Volume Changes in Aging Individuals With Normal Cognition Using Serial Magnetic Resonance Imaging

  2023cites this paper
• Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia

  2023cites this paper
• Cognitive heterogeneity in Parkinson's disease: A mechanistic view.

  2023cites this paper
• Protective effect of hot peppers against amyloid β peptide and brain injury in AlCl3-induced Alzheimer’s disease in rats

  2023cites this paper
• Molecular mechanisms of atrazine toxicity on H19-7 hippocampal neurons revealed by integrated miRNA and mRNA "omics".

  2023cites this paper
• Magnetic Resonance Imaging Markers for Cognitive Impairment in Parkinson’s Disease: Current View

  2022cites this paper
• Metformin use and brain atrophy in nondemented elderly individuals with diabetes.

  2022cites this paper
• Morphological and Structural Network Analysis of Sporadic Alzheimer’s Disease Brains Based on the APOE4 Gene

  2022cites this paper
• Frontostriatal and limbic contributions to cognitive decline in Parkinson's disease

  2022cites this paper
• Predicting cognitive decline in Parkinson’s disease using FDG-PET–based supervised learning

  2022cites this paper
• Morphological basis of Parkinson disease-associated cognitive impairment: an update

  2022cites this paper
• Association Between White Matter Connectivity and Early Dementia in Patients With Parkinson Disease

  2022cites this paper
• Validation of the Alzheimer’s disease-resemblance atrophy index in classifying and predicting progression in Alzheimer’s disease

  2022cites this paper
• The epidemiology of cognitive function in Parkinson's disease.

  2022cites this paper
• The reduction of hippocampal volume in Parkinson’s disease

  2022cites this paper
• Therapies modulating insulin resistance in Parkinson's disease: A cross talk.

  2021cites this paper
• Clinical Trials for Cognitive Impairment and Dementia in Parkinson’s Disease

  2021cites this paper
• Clinical Trials for Disease-Modifying Agents in Parkinson’s Disease

  2021cites this paper
• Clinical Trials In Parkinson's Disease

  2021cites this paper
• Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.

  2021cites this paper
• Parkinson disease-associated cognitive impairment

  2021cites this paper
• Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson’s Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus

  2021cites this paper
• Cortical Thickness from MRI to Predict Conversion from Mild Cognitive Impairment to Dementia in Parkinson Disease: A Machine Learning-based Model.

  2021cites this paper
• Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson’s disease using machine learning

  2021cites this paper
• Neuropharmacological studies of ethanolic extract of Vaccinium corymbosum on Alzheimer’s type dementia and catatonia in Swiss albino mice

  2021cites this paper
• Modelling cognitive deficits in Parkinson's disease: Is CA2 a gateway for hippocampal synucleinopathy?

  2020cites this paper
• Predictors of cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis of prospective cohort studies

  2020cites this paper
• for Disease-Modifying Agents in Parkinson’s

  2020cites this paper
• for Cognitive Impairment and Dementia in Parkinson’s

  2020cites this paper
• Application of the anatomical fiducials framework to a clinical dataset of patients with Parkinson’s disease

  2020cites this paper
• Parkinson Disease Propagation Using MRI Biomarkers and Partial Least Squares Path Modeling

  2020cites this paper
• Association of Hippocampal Subfields, CSF Biomarkers, and Cognition in Patients With Parkinson Disease Without Dementia

  2020cites this paper
• Tau pathology associates with in vivo cortical thinning in Lewy body disorders

  2020cites this paper
• Brain iron deposition is linked with cognitive severity in Parkinson’s disease

  2020cites this paper
• Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes

  2020cites this paper
• Stress and Psychiatric Disorders: The Role of Mitochondria.

  2020cites this paper
• Parkinson’s Disease-Cognitive Rating Scale for Evaluating Cognitive Impairment in Parkinson’s Disease: A Systematic Review

  2020influential citation
• Factor analysis–derived cognitive profile predicting early dementia conversion in PD

  2020cites this paper
• A Comparison of Serial Position Effects in Patients with Mild Cognitive Impairment due to Parkinson’s Disease or to Alzheimer’s Disease

  2020cites this paper
• Parietal Perfusion Alterations in Parkinson's Disease Patients Without Dementia

  2020cites this paper
• Lymphocyte-Activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-Synuclein Spreading Pathology

  2020cites this paper
• Impaired sleep quality and cognition in patients of Parkinson's disease with REM sleep behavior disorder: a comparative study.

  2019cites this paper
• General Discussion and Future Perspectives

  2019cites this paper
• Biomarkers for Dementia, Fatigue, and Depression in Parkinson's Disease

  2019cites this paper
• Auditory brain oscillatory responses in drug-naïve patients with Parkinson's disease.

  2019cites this paper
• A divergent breakdown of neurocognitive networks in Parkinson's Disease mild cognitive impairment

  2019cites this paper
• The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

  2019cites this paper
• Neural correlates of early cognitive dysfunction in Parkinson's disease

  2019cites this paper
• Mild cognitive impairment in Parkinson's disease is associated with decreased P300 amplitude and reduced putamen volume.

  2019cites this paper
• Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment

  2019influential citation
• Predicting Onset of Dementia in Parkinson's Disease Patients

  2019cites this paper
• Neuroimaging in Parkinson’s disease dementia: connecting the dots

  2019cites this paper
• Apathy as a behavioural marker of cognitive impairment in Parkinson’s disease: a longitudinal analysis

  2019cites this paper
• The Influence of Body Mass Index at Diagnosis on Cognitive Decline in Parkinson's Disease

  2019cites this paper
• Gray Matter Changes in Parkinson’s and Alzheimer’s Disease and Relation to Cognition

  2019cites this paper
• Neuroimaging in aging and neurologic diseases.

  2019cites this paper
• Enhancing cognitive and functional assessment for Alzheimer’s disease

  2019cites this paper
• Neuroscientific Research for Management of Dementia

  2019cites this paper
• OP-BRCM190009 1..17

  2019cites this paper
• IMAGING PARKINSON ’ S DISEASE : Gray Matter Atrophy Associated With Motor Dysfunction

  2019cites this paper
• Patterns of Grey Matter Atrophy at Different Stages of Parkinson’s and Alzheimer’s Diseases and Relation to Cognition

  2018cites this paper
• Structural MRI in Idiopathic Parkinson's Disease.

  2018cites this paper
• Regional expression of genes mediating trans-synaptic alpha-synuclein transfer predicts regional atrophy in Parkinson disease

  2018cites this paper
• Biomarkers for cognitive dysfunction in Parkinson's disease.

  2018cites this paper
• APOE, thought disorder, and SPARE‐AD predict cognitive decline in established Parkinson's disease

  2018cites this paper
• New Imaging Markers for Movement Disorders

  2018cites this paper
• Neuropsychologische, neuropsychiatrische und elektroencephalografische Aspekte der Apathie bei Patienten mit der Parkinsonerkrankung

  2018cites this paper
• Morphological and Pathological Characteristics of Brain in Diabetic Encephalopathy

  2018cites this paper
• Networked Data Analytics: Network Comparison And Applied Graph Signal Processing

  2018cites this paper
• Acute Dementia After Deep Brain Stimulation in Parkinson Disease.

  2018cites this paper
• Gray Matter Atrophy Associated With Motor Dysfunction

  2018cites this paper
• Can neuroimaging predict dementia in Parkinson’s disease?

  2018cites this paper